HCM priced their IPO on the US market (NASDAQ:HCM) at $13.50. The shares already trade in London (AIM:HCM).

Investors can find plenty of details in the HCM IPO roadshow slide deck but there are some major takeaways here:

  1. China will be a huge market for healthcare - per capita spending today is $322 versus over $8K in the US. End markets there are growing between 15% and 20% per year.
  2. HCM uses a hybrid strategy - they are a major drug seller and distributor and they use that growing profitable cash flow to . . .

    Want the rest of the article?

    Please login or join us as a member to view our complete content!